JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, published by the Endocrine Society, stands as a premier academic journal within the field of endocrinology, diabetes, and metabolism. With a legacy spanning from 1941 to 2024, this journal is distinguished by its significant impact factor, ranking in the Q1 category across multiple related disciplines including biochemistry, clinical biochemistry, and medicine. This esteemed journal, ISSN 0021-972X and E-ISSN 1945-7197, is backed by rigorous peer review, ensuring the publication of high-quality research that contributes to the advancement of clinical practices and scientific knowledge. With a commendable Scopus ranking, positioned in the top percentile of multiple categories, JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM serves as an essential resource for researchers, professionals, and students who seek to stay informed about the latest findings and innovations in endocrine research. The journal enriches the existing body of knowledge and fosters discussion among scholars and practitioners alike, solidifying its crucial role in the ongoing discourse in endocrinology and metabolic health.

Pituitary is a prominent academic journal dedicated to advancing the understanding of pituitary gland functions, disorders, and treatments within the sphere of Endocrinology, Diabetes, and Metabolism. Published by Springer in the Netherlands, this journal has established itself as a crucial resource for researchers and clinicians alike, as evidenced by its 2023 Category Quartiles ranking in Q2 and Q1, and a commendable Scopus ranking in both Medicine and Biochemistry. With a focus on innovative research and clinical advances, Pituitary covers a wide range of topics including hormone regulation, pituitary tumors, and endocrine therapies. While it does not currently offer Open Access options, the journal's rigorous peer-review process ensures that each article published contributes significantly to the scientific community's knowledge base. Researchers, professionals, and students will find Pituitary an invaluable resource for both current insights and ongoing developments in endocrine health.

Case Reports in Endocrinology is a pioneering open access journal published by HINDAWI LTD, dedicated to advancing the field of endocrinology through the publication of case reports that illuminate the complexities of hormone-related disorders and metabolic issues. With its ISSN 2090-6501 and E-ISSN 2090-651X, the journal has been accessible since 2011, inviting contributions from researchers, clinicians, and students worldwide. Based in the United States, Case Reports in Endocrinology aims to disseminate critical insights and unique case analyses that contribute to the broader understanding of endocrinological conditions. While currently ranked Q4 in Endocrinology, Diabetes, and Metabolism, with Scopus placing it in the 29th percentile, the journal strives to enhance its impact and visibility. By fostering an environment for knowledge sharing and collaboration in a rapidly evolving field, this journal serves as an essential resource for those looking to deepen their understanding of endocrinological complexities and improve clinical practices.

Acta Endocrinologica-Bucharest is a vital resource for those engaged in the study and practice of endocrinology, diabetes, and metabolic research. Published by EDITURA ACAD ROMANE, this journal emphasizes the dissemination of high-quality research and insights specific to the fields of endocrinology and autonomic systems. Although categorized in the lower quartiles of its subject areas according to the latest rankings—Q4 in Endocrine and Autonomic Systems and Q4 in Endocrinology—it serves as an important platform for emerging scientific ideas and collaborative studies within the endocrinology community. With an ISSN of 1841-0987 and an E-ISSN of 1843-066X, the journal provides a significant opportunity for authors to contribute to the growing body of knowledge in these fields from its base in Romania. Researchers and practitioners alike will find valuable contributions that reflect both contemporary challenges and advances in endocrinology, reinforcing the journal's commitment to enhancing scholarly communication.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES is a distinguished journal published by GEORG THIEME VERLAG KG, dedicated to advancing research and understanding in the fields of endocrinology, diabetes, and metabolism. With an ISSN of 0947-7349 and an E-ISSN of 1439-3646, this journal serves as a critical platform for disseminating high-quality research findings, reviews, and clinical studies from 1983 to 2024. The journal holds an impactful position within its respective categories, notably achieving Q3 in Endocrinology and Diabetes and Metabolism, and Q2 in Internal Medicine as per the 2023 category quartiles. Additionally, it ranks in the 57th and 46th percentiles in the Scopus rankings for Internal Medicine and Endocrinology, Diabetes and Metabolism, respectively. Though not an open-access publication, the journal caters to a global audience of researchers, professionals, and students, facilitating knowledge exchange and fostering collaboration within this vital area of medical science.

Journal of Endocrinology Metabolism and Diabetes of South Africa, published by Routledge Journals, Taylor & Francis Ltd, serves as a vital platform for advancing research and knowledge dissemination in the fields of endocrinology, metabolism, and diabetes. Since its transition to Open Access in 2012, it has enabled greater accessibility to crucial findings and data, broadening its reach to researchers, practitioners, and students alike. Though its coverage in Scopus was discontinued in 2018, the journal continues to play an important role in fostering discourse in the medical community, as evidenced by its ranking within the 19th and 16th percentiles for Internal Medicine and Endocrinology, diabetes and metabolism, respectively. With its commitment to addressing pressing health issues in South Africa and beyond, this journal remains an invaluable resource for those seeking to understand and tackle the complexities of metabolic diseases.

Journal of the Endocrine Society, published by the ENDOCRINE SOC, stands as a prominent platform for disseminating significant research and findings within the field of endocrinology, diabetes, and metabolism. Established as an Open Access journal since 2017, it aims to increase the visibility and accessibility of vital scholarly contributions, allowing researchers and professionals from various backgrounds to engage with the latest insights in this rapidly evolving discipline. With an impressive Q2 ranking in Endocrinology, Diabetes and Metabolism, the journal is recognized for its impact, ranking #100 out of 244 in Scopus, highlighting its role in advancing scientific knowledge and fostering innovation. The journal, based in the United States at 2055 L ST NW, SUITE 600, WASHINGTON, DC 20036, continues to enrich the academic landscape by converging state-of-the-art research and clinical applications through its publication cycle from 2017 to 2024. Researchers, students, and healthcare professionals are encouraged to explore this essential resource to stay at the forefront of endocrinological advancements.

GROWTH HORMONE & IGF RESEARCH is a renowned scholarly journal published by Churchill Livingstone, focusing on advancements in the field of endocrinology, particularly relating to growth hormone and insulin-like growth factors. With an ISSN of 1096-6374 and an E-ISSN of 1532-2238, the journal has established its footprint in the academic community since its inception in 1998, aiming to disseminate high-quality research through rigorous peer review up to the year 2024. Currently holding a category quartile ranking of Q3 in both Endocrinology and Endocrinology, Diabetes and Metabolism, the journal is recognized for its contribution to understanding the complexities of hormonal regulation and metabolic processes. Researchers and professionals benefit from the insights shared in this publication, which bridges gaps between advanced research and clinical practice. Open access options enhance the visibility and accessibility of published studies, fostering an inclusive academic environment for all. The journal is based in the United Kingdom, with production managed at its address in Edinburgh. By providing a dedicated platform for innovative research, GROWTH HORMONE & IGF RESEARCH continues to be an essential resource for those engaged in the evolving domains of endocrinology.

JOURNAL OF ENDOCRINOLOGY, established in 1946 and published by BIOSCIENTIFICA LTD, stands as a premier scholarly outlet in the field of endocrinology, diabetes, and metabolism. With an impressive H-Index reflecting its significant contribution to the literature, this journal maintains a strong presence in academic circles, evidenced by its Q1 ranking in the 2023 Scopus categories for both Endocrinology and Diabetes and Metabolism. With its targeted scope serving a global audience of researchers, professionals, and students, it provides a vital platform for disseminating innovative research findings and advancing the scientific understanding of endocrine systems. As we approach its convergence year of 2024, JOURNAL OF ENDOCRINOLOGY remains committed to publishing high-quality, peer-reviewed articles that explore cutting-edge developments in the field, thereby impacting clinical practices and guiding future research directions.

Journal of Clinical Research in Pediatric Endocrinology is a premier open-access journal dedicated to advancing the field of pediatric endocrinology through rigorous research and innovative findings. Published by GALENOS PUBL HOUSE, this journal has established itself as a key resource since its inception in 2008, serving a broad audience of researchers, healthcare professionals, and students in the fields of endocrinology, pediatrics, and child health. With an impact factor reflecting its significance (currently ranked in the Q2 and Q3 quartiles across multiple relevant categories), it provides a platform for high-quality peer-reviewed articles that encompass clinical observations, experimental studies, and reviews. The journal operates under an open-access model, ensuring that findings are accessible to a global audience, fostering collaborative solutions for the challenges in pediatric endocrine disorders. Residing in Turkey, the journal continues to impact the scientific community by disseminating valuable research that promotes better understanding and treatment of hormonal and metabolic disorders in children.